Skip to main content
. 2017 Jul 24;38(11):1911–1923. doi: 10.1177/0271678X17719790

Figure 4.

Figure 4.

Fagan nomogram of LSA-sign+ for different clinical endpoints.

Left axis, pretest probability; middle axis, likelihood ratio with 95% confidence interval (brackets); right axis, posttest probability with 95% confidence interval (brackets) for the respective endpoints: (a) good neurologic outcome; (b) substantial neurologic improvement; (c) good functional short-term outcome; (d) good functional mid-term outcome; Red indicates LSA-sign+, blue indicates LSA-sign.